CBDBuzzz.com
  • Home
  • News
  • Culture
  • Science
  • Health
  • Videos
  • Shop
No Result
View All Result
CBDBuzzz.com
  • Home
  • News
  • Culture
  • Science
  • Health
  • Videos
  • Shop
No Result
View All Result
CBDBuzzz.com
No Result
View All Result

(CCHWF), (CWBHF) – Cannabis Industry Alliance To Explore CBD’s Liver Effects

June 11, 2020
in Science
Reading Time: 2 mins read
A A
(CCHWF), (CWBHF) – Cannabis Industry Alliance To Explore CBD’s Liver Effects
399
SHARES
2.3k
VIEWS
ShareShareShareShareShare

Clinical research and data firm ValidCare LLC is joining major CBD companies on an industrywide studying focusing on the effects cannabidiol has on the liver.

The participants in the study will include Boulder Botanical & Bioscience Labs, CBDistillery, CBD American Shaman, Charlotte’s Web (OTC: CWBHF), Columbia Care (OTC: CCHWF), HempFusion and Kannaway.

The analysis will focus on measuring the effects on the liver from daily use of hemp-derived CBD and CBD isolate by healthy adults.

The companies are answering the FDA’s repeated request for commentary on the topic, including the agency’s March 5 report to Congress, where it asked for science-based data to confidently determine the appropriate regulatory paths for hemp derived CBD products.

The CBD Study: The observational study was designed with significant input from the FDA, the brands and third-party principal investigators Keith Aqua, MD and Jeffrey Lombardo PharmD, BCOP – both respected and peer reviewed medical doctors and PhDs in biostatistics.

The study is expected to start in the third quarter and wrap by the end of the year. The design calls for participation by a minimum of 700 consumers and will collect personal histories, blood tests and product data, to provide investigators with the opportunity to understand multiple variables across populations, products and lifestyles

See also: Marijuana CEO Sends Letter To Trump, Asking Non-Violent Cannabis Offenders Be Immediately Released From Prison

“By being [the data] both science and data-driven we can secure long term consumer trust, while also addressing the FDA’s safety concerns with CBD products,” Tim Orr, Charlotte’s Web vice president, told Benzinga. 

Why It Matters: Last year, the FDA issued a consumer advisory regarding products containing cannabis or cannabis-derived compounds.

The agency said CBD has “the potential to harm,” and “can cause liver injury.” The agency added that it has seen only limited data about CBD safety, and that it pointed to real risks that need to be considered before taking CBD for any reason.

This comes at a time when both the FDA and FTC have issued warnings and complaints to companies marketing CBD products with unproven medical claims and that are of unknown quality.

Studies such as this one by ValidCare could provide valuable real-world data to inform future FDA rulings on the science, safety and quality of products containing CBD.

 “We hope to reveal real world evidence that supports daily CBD use in healthy adults and with the advancement of this study, we will better equip the cannabis community about its health benefits,” said Rosemary Mazanet, chief science officer at Columbia Care. 

Noticias sobre cannabis en Español en El Planteo.

Lead image by Ilona Szentivanyi. Copyright: Benzinga.

© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Credit: Source link

Share160Tweet100SendShare28Pin36
Previous Post

5 Ways to Improve Your Health and Life Using CBD

Next Post

La NBA no hará test de drogas recreativas en la reanudación de la temporada

Related Posts

FDA declines to regulate CBD; calls on Congress for fix
Science

FDA declines to regulate CBD; calls on Congress for fix

January 26, 2023
Why does cannabis keep some people skinny? Experts explain how weed and metabolism are connected
Science

Why does cannabis keep some people skinny? Experts explain how weed and metabolism are connected

January 26, 2023
Curaleaf International Announces Landmark Product Registration in Poland
Science

Aurora Cannabis to Host Second Quarter Fiscal Year 2023 Investor Conference Call

January 26, 2023
Schumer presses DOJ nominees on cannabis (Newsletter: February 4, 2021)
Science

DE & MN cannabis legalization bills advance (Newsletter: January 26, 2023)

January 26, 2023
Load More
Next Post
La NBA no hará test de drogas recreativas en la reanudación de la temporada

La NBA no hará test de drogas recreativas en la reanudación de la temporada

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent Updates

FDA declines to regulate CBD; calls on Congress for fix

FDA declines to regulate CBD; calls on Congress for fix

January 26, 2023
Como Conservar La Marihuana Por Mucho Tiempo

Como Conservar La Marihuana Por Mucho Tiempo

January 26, 2023
Soft Secrets “Perfect Grow” What Makes a Great Seed?

Soft Secrets “Perfect Grow” What Makes a Great Seed?

January 26, 2023
Huge decision: FDA won’t restrict CBD sales, calls for ‘new regulatory pathway’ to assure safety

Huge decision: FDA won’t restrict CBD sales, calls for ‘new regulatory pathway’ to assure safety

January 26, 2023
Health Canada: Let’s Ban Potent Cannabis Extracts  – Cannabis | Weed | Marijuana

Health Canada: Let’s Ban Potent Cannabis Extracts  – Cannabis | Weed | Marijuana

January 26, 2023
CBDBuzzz.com

This is an online news portal that aims to share latest news about "News, Culture, Science, Health, Shop" and much more stuff like that. Feel free to get in touch with us!

Recent News

FDA declines to regulate CBD; calls on Congress for fix

FDA declines to regulate CBD; calls on Congress for fix

January 26, 2023
Como Conservar La Marihuana Por Mucho Tiempo

Como Conservar La Marihuana Por Mucho Tiempo

January 26, 2023

Subscribe Now

Loading
  • Contact Us
  • Privacy Policy

© 2020 matans3.sg-host.com - All rights reserved!

No Result
View All Result
  • Home
  • News
  • Culture
  • Science
  • Health
  • Videos
  • Shop

© 2020 matans3.sg-host.com - All rights reserved!